28.50
-1.80
(-5.94%)
At close: 2:59:56 PM GMT+8
Key Executives
Amounts are as of -- and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in TWD.
| Name | Title | Pay | Exercised | Year Born |
|---|---|---|---|---|
| Mr. Chun-Tong Huang | General Manager | -- | -- | -- |
| Yi Xin Zhang | Chief Financial Officer | -- | -- | -- |
| Zhi Cheng Lu | Chief Operating Officer | -- | -- | -- |
| Mr. Calvin Tsai | GM & Director | -- | -- | -- |
Orient Pharma Co., Ltd.
No. 368, Fu Hsing South Road
2nd Floor Section 1
Taipei, 106
Taiwan
- Sector:
- Healthcare
- Industry: Drug Manufacturers - Specialty & Generic
Description
Orient Pharma Co., Ltd. engages in the research and development, manufacturing, and sales of drugs in Taiwan and internationally. The company develops anti-psychotics and psychostimulants, as well as drugs for treating Parkinson's and Alzheimer's diseases; and products for the treatment of sialorrhea, tuberculosis, and attention deficit hyperactivity disorder. It is also developing drug delivery technologies, such as multi-stages-controlled release technology, trans-dermal patches, oral disintegrating tablets, sustained release technology, and micro granules. The company was founded in 2008 and is based in Taipei, Taiwan.
Corporate Governance
Orient Pharma Co., Ltd.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.
Upcoming Events
Upcoming Events Information Not Available
Recent Events
Recent Events Information Not Available
Related Tickers
4120.TWO Orient EuroPharma Co., Ltd.
44.10
-1.23%
6467.TWO TAHO Pharma
55.90
-5.89%
4172.TWO InnoPharmax Inc.
15.45
+0.32%
6677.TWO Anxo Pharmaceutical Co., Ltd.
18.65
-1.84%
6621.TWO UniPharma Co., Ltd.
16.10
0.00%
7561.TWO Bioray Biotech Co., Ltd
20.05
0.00%
6932.TWO Mercury Biopharmaceutical Corporation
12.70
-0.78%
6539.TWO DV Biomed Co., Ltd.
64.00
+3.23%
6620.TWO Handa Pharmaceuticals, Inc.
70.10
-1.82%
4132.TWO Golden Biotechnology Corporation
13.05
0.00%